Wolfe Research Initiates Coverage On Pharvaris with Outperform Rating, Announces Price Target of $42
Benzinga Newsdesk 7 months ago
NewsPrice TargetInitiationAnalyst Ratings
Wolfe Research analyst Andy Chen initiates coverage on Pharvaris (NASDAQ:PHVS) with a Outperform rating and announces Price Target of $42.
Wolfe Research analyst Andy Chen initiates coverage on Pharvaris (NASDAQ:PHVS) with a Outperform rating and announces Price Target of $42.